Commission Regulation (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 1999-05-05
Institutions: European Commission
Subjects: animal product, food inspection, foodstuff, veterinary drug, waste

6. 5. 1999

EN

Official Journal of the European Communities

L 118/23

COMMISSION REGULATION (EC) No 953/1999

of 5 May 1999

amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying
down a Community procedure for the establishment of maximum residue limits
of veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Regulation (EEC) No 2377/90
of 26 June 1990 laying down a Community procedure for
the establishment of maximum residue limits of veter-
inary medicinal products in foodstuffs of animal origin (1),
as last amended by Commission Regulation (EC) No 804/
1999 (2) and in particular Articles 6, 7 and 8 thereof,

(1) Whereas, in accordance with Regulation (EEC) No
2377/90, maximum residue limits must be estab-
lished progressively for all pharmacologically active
substances which are used within the Community
in veterinary medicinal products
intended for
administration to food-producing animals;

(2) Whereas maximum residue limits should be estab-
lished only after
the examination within the
Committee for Veterinary Medicinal Products of all
the relevant information concerning the safety of
residues of
the
consumer of foodstuffs of animal origin and the
impact of residues on the industrial processing of
foodstuffs;

the substance concerned for

(3) Whereas, in establishing maximum residue limits
for residues of veterinary medicinal products in
foodstuffs of animal origin, it is necessary to specify
the animal species in which residues may be
present, the levels which may be present in each of
the relevant meat tissues obtained from the treated
animal (target tissue) and the nature of the residue
which is relevant for the monitoring of residues
(marker residue);

maximum residue limits
always be established for muscle or fat tissues;

should therefore also

(5) Whereas, in the case of veterinary medicinal pro-
ducts intended for use in laying birds,
lactating
animals or honey bees, maximum residue limits
must also be established for eggs, milk or honey;

(6) Whereas parconazole should be inserted into
Annex II to Regulation (EEC) No 2377/90;

(7) Whereas, in order to allow for the completion of
scientific studies, imidocarb, carazolol, pirlimycin,
danofloxacin,
josamycin and bacitracin should be
inserted into Annex III to Regulation (EEC) No
2377/90;

(8) Whereas a period of 60 days should be allowed
before the entry into force of this Regulation in
order to allow Member States to make any adjust-
ment which may be necessary to the authorisations
veterinary medicinal products
to place
concerned on the market which have been granted
in
81/
accordance with Council Directive
851/EEC (3), as last amended by Directive 93/
40/EEC (4) to take account of the provisions of this
Regulation;

the

(9) Whereas the measures provided for in this Regula-
tion are in accordance with the opinion of the
Standing Committee on Veterinary Medicinal
Products,

HAS ADOPTED THE FOLLOWING REGULATION

Article 1

Annexes II and III of Regulation (EEC) No 2377/90 are
hereby amended as set out in the Annex hereto.

(4) Whereas, for the control of residues, as provided for
in appropriate Community legislation, maximum
residue limits should usually be established for the
target tissues of liver or kidney; whereas, however,
the liver and kidney are frequently removed from
and
carcasses moving in international

trade,

Article 2

This Regulation shall enter into force on the 60th day
following its publication in the Official Journal of the
European Communities.

(1) OJ L 224, 18.8.1990, p. 1.
(2) OJ L 102, 17.4.1999, p. 58.

(3) OJ L 317, 6.11.1981, p. 1.
(4) OJ L 214, 24.8.1993, p. 31.

L 118/24

EN

Official Journal of the European Communities

6. 5. 1999

This Regulation shall be binding in its entirety and directly applicable in all Member
States.

Done at Brussels, 5 May 1999.

For the Commission

Martin BANGEMANN

Member of the Commission

A. Annex II to Regulation (EEC) No 2377/90 is amended as follows:

2.

Organic compounds

ANNEX

Pharmacologically active substance(s)

Animal species

Other provisions

‘Parconazole

Guinea fowl'

B. Annex III to Regulation (EEC) No 2377/90 is amended as follows:

1.

Anti-infectious agents

1.2.

Antibiotics

1.2.2. Macrolides

Pharmacologically active
substance(s)

‘Josamycin

1.2.6. Quinolones

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

Sum of the microbiolog-
ically active metabolites,
expressed as josamycin

Porcine

200 lg/kg Muscle
200 lg/kg
200 lg/kg
400 lg/kg Kidney

Skin and fat
Liver

Provisional

MRLs

expire

on

1.7.2002'

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Danofloxacin

Danofloxacin

Porcine

100 lg/kg Muscle
50 lg/kg
200 lg/kg
200 lg/kg Kidney

Skin and fat
Liver

Provisional

MRLs

expire

on

1.1.2000'

6

.

5

.

1
9
9
9

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e
E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

L
1
1
8
/
2
5

1.2.12. Polypeptides

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Bacitracin

Bacitracin

Bovine

150 lg/kg Milk

Provisional MRLs expire on 1.7.2001'

1.2.13. Lincosamides

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Pirlimycin

Pirlimycin

Bovine

Provisional

MRLs

expire

on

1.7.2000'

100 lg/kg Muscle
100 lg/kg
1 000 lg/kg

Fat
Liver

400 lg/kg Kidney
100 lg/kg Milk

2.

Antiparasitic agents

2.4.

Agents acting against protozoa

2.4.1. Carbanilides

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Imidocarb

Imidocarb

Bovine, ovine

Provisonal

MRLs

expire

on

1.1.2002'

300 lg/kg Muscle
50 lg/kg
2 000 lg/kg
1 500 lg/kg Kidney
50 lg/kg Milk

Fat
Liver

L
1
1
8
/
2
6

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e
E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

6

.

5

.

1
9
9
9

3.

3.2.

Agents acting on the nervous system

Agents acting on the autonomic nervous system

3.2.2. Anti-adrenergics

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Carazolol

Carazolol

Bovine

Provisional

MRLs

expire

on

1.1.2000'

5 lg/kg Muscle
5 lg/kg
15 lg/kg
15 lg/kg Kidney
1 lg/kg Milk

Fat
Liver

6

.

5

.

1
9
9
9

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e
E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

L
1
1
8
/
2
7